alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Joseph L. GIBSON, petitioner, v. John OLIVER, Warden.

No. 12-8985.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
Tommy W. ANDERSON v. STATE

CR-16-1049

Court of Criminal Appeals of Alabama.

January 5, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Reh. denied.
Orlando HERNANDEZ, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-1249

District Court of Appeal of Florida, Third District.

Opinion filed June 26, 2019.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
スキンケア製品の安全性:

FDA ハイドロキノン

ハイドロキノンという成分を含む美白化粧品は、害を及ぼす可能性があります。

気を付けましょう!

ハイドロキノンを含むスキンケア製品は、認可を

受けた専門医師によって処方された場合にのみ、

使用してください。 

処方箋なしの皮膚用製品を購入または使用する前

に、製品ラベルにハイドロキノンが含まれている

かどうかを確認してください。

美白化粧品

について知っておくべきこと

肌の色ムラを補正する

黒ずみ、シミ、シワを取り除く

スキンケア製品の安全性については、

www.fda.gov/SkinFacts、「Get the Skin Facts!」

をご覧ください。 

ハイドロキノンは、美白化粧品の有

効成分として使用されています:

皮膚の変色(オクロノシス)は、

恒久的の変色の可能性があります

発疹

顔のむくみや腫れ

これらの製品の使用による 深刻な副

作用が、報告されています:

知って

いますか?

ハイドロキノンを使用した美白化粧品

は、米国ではFDAの処方箋無しでの店頭販売

許可を得ていません。
スキンケア製品の安全性:水銀

水銀を成分として含む美白化粧品は、害を及ぼす可能性があります。

美白化粧品

について知っておくべきこと

スキンケア製品の安全性については、

www.fda.gov/SkinFacts、「Get the Skin Facts!」

をご覧ください。 

知って

いますか?

FDAは美白化粧品に水銀を使用するこ

とを、禁止しています。

水銀を含む皮膚用製品を使用する

と、次のような深刻な健康障害を

引き起こす可能性があります:

目、肺、腎臓への害 消化器系、

免疫系、神経系への害

皮膚の発疹や感染

皮膚が褐色・灰色に変色

Ingredients: Linalool,

Aqua, Glycerin, Parfum,

Isomethyl Ionone,

Calomel, Xanthan,

Hydrogenated Veg Oil.

また、水銀中毒は昏睡状態を引き起

こし、死に至ることもあります。

これらの成分を含む製品を使用し

たり、購入したり、しないでくだ

さい。

製品の成分表示で水銀を表す用語が

あるかどうかを確認してください:

塩化水銀 

カロメル

Mercuric

Mercurio

Hg

すぐに毒物管理センター

1-(800)-222-1222 に電話

し、 医師に連絡してくだ

さい。

水銀に触れた手や 他の体

の部分を、 よく洗うこ

と。

水銀を使用したスキンケア

製品は、 お近くの危険物

廃棄センターに 持ち込ん

でください。

あなたや、あなたの家族の誰かが水銀にさらされた場合: 

Ingredients: Linalool, 

Aqua, Glycerin, Parfum, 

Isomethyl Ionone, 

Calomel, Xanthan,

Hydrogenated Veg Oil.

Ingredients: Lina

Aqua, Glycerin, Pa

Isomethyl Ionone, 

Calomel, Xanthan

Hydrogenated Ve
ラベルが無い製品、手製のラベル、英語で書かれていない製品などは、絶対に避けてください。

スキンケア製品の安全性:

FDA 危険な製品の識別

ハイドロキノンという成分を含む美白化粧品は、害を及ぼす可能性があります。

美白化粧品

について知っておくべきこと

スキンケア製品の安全性については、

www.fda.gov/SkinFacts、「Get the Skin Facts!」

をご覧ください。 

皮膚の色を明るくする

石鹸 

肌の色を均一にする化

粧水

美白パウダー

スポット補正クリーム

ケミカルピーリング

注意 

FDAはハイドロキノンまたは水銀を含む化粧

品および処方箋無しの(市販)スキンケア製

品の使用による、深刻な副作用の報告を受け

ています。これらの製品の店頭販売は、米国

では違法とされています。

見分ける

美白化粧品は、以下のような記述で識別でき

ることがあります。

調べましょう

美白化粧品を購入・使用する前に ラベルでハイ

ドロキノンや水銀が含まれているかどうかを確認

してください。

水銀は、以下のように記載されている場合

もあります。

以下の皮膚の状態を治療するのに使用する:

肝斑

そばかす 

にきび

シワ

塩化水銀

カロメル

Mercuric

Mercurio

Hg

FDAはこれらの製品の使用を控えるようアドバイス

し、消費者に治療法について専門医師と相談するよう

促しています。
#### Richard Arthur WRIGHT, Jr., Petitioner—Appellant, v. Edward S. ALAMEIDA, Jr., Director, Respondent—Appellee.

No. 03-16781.

D.C. No. CV-02-03607-PJH.

United States Court of Appeals, Ninth Circuit.

Submitted April 12, 2004.*

Decided April 19, 2004.

*457Robert Franklin Howell, Santa Barbara, CA, for Petitioner-Appellant.

Seth K. Schalit, Pamela K Critchfield, San Francisco, CA, for Respondent-Appellee.

Before HALL, O’SCANNLAIN, and RYMER, Circuit Judges.

*

 This panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM**

Richard Arthur Wright, Jr., appeals the district court’s denial of his petition for a writ of habeas corpus pursuant to 28 U.S.C. § 2254 alleging ineffective assistance of counsel due to his attorney’s failure to file a motion to suppress eyewitness identification testimony. We have jurisdiction under 28 U.S.C. §§ 1291 and 2253. We review de novo the district court’s decision to deny a 28 U.S.C. § 2254 petition, *see Alcala v. Woodford,*334 F.3d 862, 868 (9th Cir.2003), and we affirm.

Although his trial counsel failed to file a motion to suppress evidence, Wright did not receive ineffective assistance of counsel because counsel’s action was not constitutionally deficient. *See Strickland v. Washington,*466 U.S. 668, 687, 104 S.Ct. 2052, 80 L.Ed.2d 674 (1984). Petitioner alleges that the eyewitness identification was obtained in violation of his Sixth Amendment right to counsel during a post-lineup meeting between the victim and police officer because his attorney was absent. This is incorrect. *See Doss v. United States,*431 F.2d 601, 603 (9th Cir.1970) (holding that witness interviews after lineups do not trigger the right to counsel). Wright’s attorney’s failure to move to suppress was not objectively unreasonable conduct. *Id.*Accordingly, the California court’s adjudication did not result in a decision that was contrary *to, or*involved an unreasonable application of, clearly established federal law, as determined by the Supreme Court of the United States.

AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

SEAN EUGENE TAPP,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 185 MM 2016

ORDER

PER CURIAM

AND NOW , this 2nd day of February , 201 7

, the Application for Leave to File

Original Process is GRANTED

, and the Petition for Writ of Mandamus and/or

Extraordinary Relief and the Application for an Immediate Hearing are DENIED

.
2019冠状病毒肺炎疫苗从研究到紧急使用授权的路径

疫苗制造商进行实验室研究以研

制出一种疫苗。

制造商汇编实验室研究和动物试验的

结果,以及有关生产技术和疫苗质量

的信息,并必须在开始人体临床试验

前向美国食品及药物管理局提交一份

研究性新药申请。没有美国食品及药

物管理局的书面授权,这样的人体临

床试验是不允许进行的。

进行临床试验以获得有关疫苗安全性

和有效性的数据。

数据安全监视委员会评估来自3期临床

试验的数据,并就其2019冠状病毒疫苗

是否已满足美国食品及药物管理局预先

讨论并同意的预先指定临床终点标准,

向疫苗制造商提供建议。

该公司审查数据,以确定该公司的科

学家和技术专家是否相信该疫苗满足

美国食品及药物管理局对安全性和有

效性的预期。

考量来自美国食品及药物管理局的信

息,公司决定是否以及何时提交向美国

食品及药物管理局申请紧急使用授权。

一旦提交,美国食品及药物管理局生

物制剂评估和研究中心的职业科学家

和医生将会对紧急使用授权申请进行

评估,并考虑到所有与疫苗相关的科

学证据。

1

美国食品及药物管理局召集疫苗及相关

生物制品咨询委员会召开公开会议,讨

论临床试验数据。

咨询委员会会议后,生物学评价及研

究中心的专业人员会考虑咨询委员会

成员意见并继续对其进行评估,以确

定其是否可用的安全性,有效性和产

品数据是否支持授权在美国使用特定

的2019冠状病毒肺炎。

如果美国食品及药物管理局确定符合

紧急使用授权的标准,包括疫苗的已

知和潜在收益大于已知和潜在风险,

以及生产信息足以确保其质量和一致

性,则美国食品及药物管理局可授权

紧急使用该疫苗。2

美国食品及药物管理局通知该公司其

紧急使用授权已获授权。

美国食品及

药物管理局

疫苗说明书

www.FDA.gov/COVID19vaccines

#美国食品及药物管理局疫苗说明书

1 美国食品及药物管理局对2019冠状

病毒肺炎疫苗的紧急使用授权要求

进行的评估包括对该疫苗的化学、

生产和控制信息进行评估。应提交

足够的数据,以确保疫苗产品的质

量和一致性。美国食品及药物管理

局将使用所有可用的工具和信息,

包括记录审查、现场访问和以前的

依从性历史,以评估当前良好制造

规范的依从性。

2 美国食品及药物管理局在其2020年

10月为防止2019冠状病毒肺炎的题为

《疫苗紧急使用授权》的指导方针中

明确表示,对于具有足够的生产信息

确认其质量和一致性的2019冠状病毒

肺炎疫苗,根据数据,需要获得紧急

使用授权,必须由美国食品及药物管

理局确认疫苗必须通过至少一个缜密

设计的3期临床试验,从而清晰明确

的证明疫苗的安全性,有效性以及疫

苗的益处远大于其风险。

美国食品及药物管

理局
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1406 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 1406

   To amend title 37, United States Code, to increase the authorized 
weight allowances for the shipment of baggage and household effects of 
       senior noncommissioned officers of the uniformed services.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 17, 2005

  Mr. Latham introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
   To amend title 37, United States Code, to increase the authorized 
weight allowances for the shipment of baggage and household effects of 
       senior noncommissioned officers of the uniformed services.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Senior NCO Household Goods Shipment 
Equity Act of 2005''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Household-goods weight allowances for a member of the 
        uniformed services during a permanent change of station move 
        are currently set as a grade-based benefit rather than 
        reflecting the normal accumulation of goods during the career 
        of the member and as the member's family grows.
            (2) An undeniable aspect of the life of a senior 
        noncommissioned officer is the jettisoning of personal property 
        prior to a permanent change of station move in order to avoid 
        the financial penalties that must be paid for household goods 
        weights that exceed the permitted weight allowances.
            (3) Increased household goods weight allowances for senior 
        noncommissioned officers and their families would serve as a 
        career incentive and provide fairness to those members who have 
        made military service a career.

SEC. 3. INCREASED WEIGHT ALLOWANCES FOR SHIPMENT OF HOUSEHOLD GOODS OF 
              SENIOR NONCOMMISSIONED OFFICERS.

    (a) Increase.--The table in section 406(b)(1)(C) of title 37, 
United States Code, is amended by striking the items relating to pay 
grades E-7 through E-9 and inserting the following new items:

 
 
 
``E-9...........................................................                        18,000           18,000
E-8.............................................................                        16,000           17,500
E-7.............................................................                        14,000        17,000''.
 

    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect on January 1, 2006, and apply with respect to an order in 
connection with a change of temporary or permanent station issued on or 
after that date.
                                 <all>
```
exv10xiiiyxayx5y



 



Exhibit (10)(iii)(A)(5)

PRIVATE




	 	 	 	 	 
	 	 	
IMPERIAL OIL LIMITED
	 	2003
	 	 	
EARNINGS BONUS UNIT AWARD	 	 









	Name of Grantee:	 	
Grant Date: Nov. 20, 2003
	Number of IEBUs:	 	
IEBU No:
	Maximum Settlement Value per IEBU: $3.00	 	
Empl. No:
	Maximum Settlement Value of Award:	 	 







This IMPERIAL EARNINGS BONUS UNIT (IEBU) AWARD is granted by Imperial Oil
Limited (the “Company”) effective November 20, 2003, (the “Grant Date”). This
Award is subject to the provisions herein stated and the Imperial Oil Limited
Earnings Bonus Unit Plan (the “Plan”) and is granted on the conditions that
Grantee accepts such provisions. The Grant Instrument incorporates by
reference the provisions of the Plan, as it may be amended from time to time,
including without limitation the definitions of terms used in this Grant
Instrument and defined in the Plan.


	1.	 	AWARD



	 	 	This incentive is provided by the grant of Imperial Oil Limited Earnings
Bonus Units (“IEBUs”), which gives the Grantee the right, subject to the
terms and conditions herein, to receive a cash payment from the Company
equal to the Maximum Settlement Value per IEBU, when the cumulative basic
net earnings per common share of the Company reach at least the Maximum
Settlement Value per IEBU prior to the fifth anniversary of the Grant
Date, or equal to the cumulative basic net earnings per common share
ending on the last full quarter that precedes the fifth anniversary of the
Grant Date if the cumulative basic net earnings per common share do not
reach the Maximum Settlement Value per IEBU.



	2.	 	SETTLEMENT DATE AND DEFERRED PAYMENTS



	 	 	The Settlement Date of these IEBUs shall be the earlier of the fifth
anniversary of the Grant Date, or the date of publication of the Company’s
quarterly earnings statements which bring the cumulative basic net
earnings per common share as initially published commencing with the first
full quarter following the Grant Date to an amount at least equal to the
Maximum Settlement Value per IEBU specified above; provided, however, in
the discretion of the Company, payment may be deferred as specified by the
Grantee based on options for such deferral provided to the Grantee by the
Company.



	3.	 	ASSIGNMENT



	 	 	No right created by the granting of an IEBU can be pledged in any
circumstance, nor can it be assigned except in the case of death. Any
attempt to pledge or assign may, in the discretion of the Company, result
in forfeiture of the rights created herein.




	 	 	 
	 	 	
IMPERIAL OIL LIMITED
	 	 	

	 	 	
Chairman, President and
Chief Executive Officer
IN THE UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF INDIANA 

SOUTH BEND DIVISION 

CAROLYN MALONEY, c/o ) 

Denny Maloney, ) 

 ) 

 Plaintiff, ) 

 ) 

v. ) Cause No. 3:12-cv-842-PPS-CAN 

 ) 

NEW ENGLAND COMPOUNDING ) 

PHARMACY, INC. a/k/a NEW ) 

ENGLAND COMPOUNDING CENTER; ) 

AMERIDOSE, LLC; ALAUNUS ) 

PHARMACEUTICAL, LLC; BARRY ) 

CADDEN; LISA CADDEN; ) 

and GREGORY CONIGLIARO, ) 

 ) 

 Defendants. ) 

UNOPPOSED MOTION FOR EXTENSION OF TIME

TO RESPOND TO PLAINTIFF’S COMPLAINT

Pursuant to L.R. 6.1., Defendants Barry Cadden, Lisa Cadden and Greg Conigliaro 

(“Defendants”), by counsel, hereby move this Court for an extension of time to respond to 

Plaintiff’s Complaint, up to and including March 25, 2013. Defendants’ Answer is currently due 

February 22, 2013. Plaintiff’s counsel has been consulted and has no objection to the requested 

extension. 

WHEREFORE, Defendants, by counsel, pray for an Order allowing Defendants up to and 

including March 25, 2013 to respond to Plaintiff’s Complaint, and for all other relief just and 

proper in the premises. 

case 3:12-cv-00842-PPS-CAN document 18 filed 02/14/13 page 1 of 2
2 

LEWIS WAGNER LLP 

By: /s/ Kameelah Shaheed-Diallo 

DINA M. COX, #18590-49 

KAMEELAH SHAHEED-DIALLO, #28058-49 

ROBERT M. BAKER IV, #25471-49 

JANELLE M. KILIES, #30708-49 

 Attorneys for Defendants 

CERTIFICATE OF SERVICE

 This is to certify that a copy of the foregoing has been filed with the Clerk of the Court 

on February 14, 2013 using the CM/ECF system which sent notification of this filing to the 

following: 

Douglas A. Mulvaney 

Stutsman & Mulvaney 

1300 Cassopolis Street 

P.O. Box 1337 

Elkhart, Indiana 46515 

Counsel for Plaintiff 

 /s/ Kameelah Shaheed-Diallo 

 KAMEELAH SHAHEED-DIALLO 

LEWIS WAGNER, LLP 

501 Indiana Avenue, Suite 200 

Indianapolis, IN 46202-6150 

Telephone: (317) 237-0500 

Facsimile: (317) 630-2790 

kshaheed-diallo@lewiswagner.com \\lwfilesrv\DOCS\NECC\14 - Maloney\Federal Court Action\2nd_MET.doc

case 3:12-cv-00842-PPS-CAN document 18 filed 02/14/13 page 2 of 2
United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

WAYMO LLC,

Plaintiff,

 v.

UBER TECHNOLOGIES, INC.;

OTTOMOTTO LLC; and OTTO

TRUCKING LLC,

Defendants. /

No. C 17-00939 WHA

ORDER SHORTENING TIME

TO BRIEF MOTION FOR

RELIEF

On July 19, Judge Jacqueline Corley issued an order on plaintiff Waymo LLC’s further

motion to compel production of certain documents and answers to interrogatories from

defendants Uber Technologies, Inc., and Ottomotto LLC (collectively, “Uber”) (Dkt. No. 951). 

Uber has filed a motion for relief from that order pursuant to Civil Local Rule 72 (Dkt. No.

1007). The deadline for response briefs is advanced from August 7 to JULY 27 AT NOON. The

deadline for any reply briefs is advanced from August 14 to JULY 28 AT NOON. Judge Corley’s

July 19 order (see Dkt. No. 951 at 2) is STAYED pending resolution of this motion.

IT IS SO ORDERED.

Dated: July 25, 2017. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:17-cv-00939-WHA Document 1015 Filed 07/25/17 Page 1 of 1
Joshua Troy DOOLY, Appellant, v. STATE of Florida, Appellee.

No. 1D18-2461

District Court of Appeal of Florida, First District.

May 6, 2019 Rehearing Denied June 17, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Troy BUTLER, petitioner, v. MONTANA.

No. 12-1251.

Supreme Court of the United States

May 28, 2013.

Petition for writ of certiorari to the Supreme Court of Montana denied.
Nicholas Wayne LOAR, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D19-2045

District Court of Appeal of Florida, Second District.

June 27, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
Frank Robert DITTO, petitioner, v. PATENT AND TRADEMARK OFFICE, Board of Patent Appeals and Interferences.

No. 12-9263.

Supreme Court of the United States

April 29, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
Dwight A. HILL, petitioner, v. ILLINOIS.

No. 12-9549.

Supreme Court of the United States

June 10, 2013.

Petition for writ of certiorari to the Appellate Court of Illinois, Fourth District, denied.
Darren Andrew PETRICKA, petitioner, v. Paul BRAZELTON, Acting Warden.

No. 12-9176.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
June 5, 2017
Gayen HANCOCK, et al., petitioners v. AT & T, Inc., et al.

No. 12-1112.

Supreme Court of the United States

April 22, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit denied.
James E. DOWNS, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D19-0448

District Court of Appeal of Florida, Second District.

June 25, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
#### Adan Silva UNZUETA; et al., Petitioners, v. John ASHCROFT, Attorney General,* Respondent.

No. 02-70888.

United States Court of Appeals, Ninth Circuit.

Submitted April 12, 2004.**

Decided April 26, 2004.

Adan Silva Unzueta, Compton, CA, pro se.

*484Arthur L. Rabin, Esq., DOJ — U.S. Department of Justice, Washington, DC, for Respondent.

Before HALL, O’SCANNLAIN, and RYMER, Circuit Judges.

*

 John Ashcroft is the proper respondent. The Clerk shall amend the docket to reflect the above caption.

**

The panel unanimously finds this case suitable for decision without oral argument. *See**484Fed. R.App. P. 34(a)(2).

MEMORANDUM ***

Adan Silva Unzueta and. his wife Lucila Hernandez-Fuentes, natives and citizens of Mexico, petition for review of the decision by the Board of Immigration Appeals (“BIA”) summarily affirming an immigration judge’s (“IJ”) decision denying their applications for cancellation of removal. We have jurisdiction under 8 U.S.C. § 1252: We deny the petition in part, and dismiss in part.

Petitioners’ contention that the BIA’s summary affirmance without an opinion violates due process is foreclosed by *Falcon Carriche v. Ashcroft,*350 F.3d 845, 848-49 (9th Cir.2003).

Petitioners’ contention that the Nicaraguan Adjustment and Central American Relief Act favors certain aliens over others and therefore violates equal protection similarly fails because the Act “easily satisfies the rational basis test.” *See Jimenez-Angeles v. Ashcroft,*291 F.3d 594, 603 (9th Cir.2002).

We lack jurisdiction over Petitioners’ contention that the IJ erred in concluding that they failed to demonstrate “exceptional and extremely unusual hardship.” *See Romero-Torres v. Ashcroft,*327 F.3d 887, 888 (9th Cir.2003).

Petitioners’ remaining contentions are also without merit.

PETITION FOR REVIEW DENIED in part; DISMISSED in part.

***

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
Melissa CASTLEBERRY, petitioner, v. FLORIDA.

No. 12-7620.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the District Court of Appeal of Florida, Second District, denied.
# JUN 04  1025AM

CDR420

Line-In Record

Other

39.235863
Carolyn TRIPLETT, petitioner, v. Patrick R. DONAHOE, Postmaster General.

No. 12-8531.

Supreme Court of the United States

May 28, 2013.

Petition for rehearing denied.
In re Fabian VAKSMAN, petitioner.

No. 12-9186.

Supreme Court of the United States

April 15, 2013.

Petition for writ of mandamus denied.
Moise CADET, petitioner, v. FLORIDA.

No. 12-6918.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the District Court of Appeal of Florida, Second District, denied.
MOORE
& ASSOCIATES, CHARTERED


ACCOUNTANTS AND
ADVISORS


PCAOB
REGISTERED










CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM











We
consent to the use, in the statement on Form 10K of Bold View Resources, Inc.,
of our report dated July 7, 2008 on our audit of the financial statements of
Bold View Resources, Inc. as of May 31, 2008 and 2007, and the related
statements of operations, stockholders’ equity and cash flows for the year ended
May 31, 2008 and inception on January 30, 2007 through May 31, 2007 and
inception on January 31, 2007  through May 31, 2008, and the reference
to us under the caption “Experts.”











/s/ Moore & Associates,
Chartered


Moore
& Associates Chartered


Las
Vegas, Nevada


August
29, 2008






























































































2675 S. Jones Blvd. Suite
109, Las Vegas, NV 89146 (702)253-7499 Fax
(702)253-7501
[Federal Register Volume 60, Number 93 (Monday, May 15, 1995)]
[Rules and Regulations]
[Pages 25851-25852]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11818]



=======================================================================
-----------------------------------------------------------------------

FEDERAL COMMUNICATIONS COMMISSION

47 CFR Part 73

[MM Docket No. 93-224; RM-8291, 8325, 8358, 8360]


Radio Broadcasting Services; Bismark, Centerville, Farmington, 
Ironton, MO, and Herrin, IL

AGENCY: Federal Communications Commission.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This document allots Channel 258C3 to Bismarck, Missouri, as 
that community's first local service, in response to a counterproposal 
filed by KREI, Inc. See 58 FR 42522, August 10, 1993. The coordinates 
for Channel 258C3 are 37-38-43 and 90-32-54. There is a site 
restriction 15.3 kilometers (9.5 miles) southeast of the community. The 
counterproposal filed by Wayne E. Tate for Ironton, Missouri, and 
Herrin, Illinois, has been dismissed (RM-8325). The counterproposal 
filed by Wayne E. Tate and David E. Smith Communications, Inc. for 
Ironton, Missouri, Herrin, Illinois and Centerville, Missouri, has been 
dismissed (RM-8360). The petition filed by KREI, Inc. for Farmington, 
Missouri, has been dismissed (RM-8291). With this action, this 
proceeding is terminated.

DATES: Effective June 23, 1995. The window period for filing 
applications for Channel 258C3 at Bismarck, Missouri, will open on June 
23, 1995, and close on July 24, 1995.

FOR FURTHER INFORMATION CONTACT: Kathleen Scheuerle, Mass Media Bureau, 
(202) 418-2180.

SUPPLEMENTARY INFORMATION: This is a summary of the Commission's Report 
and Order, MM Docket No. 93-224, adopted May 1, 1995, released May 9, 
1995. The full text of this Commission decision is available for 
inspection and copying during normal business hours in the Commission's 
Reference Center (Room 239), 1919 M Street, NW, Washington, D.C. The 
complete text of this decision may also be purchased from the 
Commission's copy contractors, International Transcription Services, 
Inc., 2100 M Street, NW, Suite 140, Washington, D.C. 20037, (202) 857-
3800.

List of Subjects in 47 CFR Part 73

    Radio broadcasting.

    Part 73 of Title 47 of the Code of Federal Regulations is amended 
as follows: [[Page 25852]] 

PART 73--[AMENDED]

    1. The authority citation for Part 73 continues to read as follows:

    Authority: Secs. 303, 48 Stat., as amended, 1082; 47 U.S.C. 154, 
as amended.


Sec. 73.202  [Amended]

    2. Section 73.202(b), the Table of FM Allotments under Missouri, is 
amended by adding Bismarck, Channel 258C3.

Federal Communications Commission.
John A. Karousos,
Chief, Allocations Branch, Policy and Rules Division, Mass Media 
Bureau.
[FR Doc. 95-11818 Filed 5-12-95; 8:45 am]
BILLING CODE 6712-01-F